Pfizer seeks a Director, Obesity Early Pipeline Commercial Development to lead end‑to‑end commercial assessments for early and mid‑stage obesity assets. You will build product concepts, shape disease‑area strategies, and guide forecasting, pricing, and demand analyses into actionable plans.
You will work across R&D and commercial teams, influencing asset direction and governance decisions. The role requires strong analytical and communication skills, experience in commercial development, and the
#J-18808-Ljbffr